共 50 条
- [1] RATIONALE OF COMBINED MODALITY THERAPY FOR CANCER [J]. CANCER CHEMOTHERAPY REPORTS PART 2 SUPPLEMENT, 1974, 4 (01): : 13 - 24
- [3] Pleural mesothelioma: combined modality treatments [J]. ANNALS OF ONCOLOGY, 2002, 13 : 217 - 225
- [4] Hypoxia as a target for combined modality treatments [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (02) : 240 - 257
- [5] IMPORTANCE OF TIMING AND DOSE IN COMBINED MODALITY TREATMENTS [J]. BRITISH JOURNAL OF RADIOLOGY, 1979, 52 (619): : 599 - 599
- [7] RATIONALE FOR COMBINED MODALITY MANAGEMENT IN SMALL CELL-CANCER OF LUNG [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 100 - 100
- [8] Is advanced nasopharyngeal carcinoma a curable disease? The rationale for combined modality therapy [J]. HEAD AND NECK CANCER, VOL 4, 1996, : 578 - 585
- [9] SMALL CELL CARCINOMAS OF THE LARYNX - RESULTS OF COMBINED MODALITY TREATMENTS [J]. LARYNGOSCOPE, 1983, 93 (07): : 946 - 948
- [10] Organ preservation approaches with combined modality treatments for bladder carcinoma [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 256 - 256